Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 680

1.

Functional CD8+ T cell responses in lethal Ebola virus infection.

Bradfute SB, Warfield KL, Bavari S.

J Immunol. 2008 Mar 15;180(6):4058-66.

2.

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.

Warfield KL, Olinger G, Deal EM, Swenson DL, Bailey M, Negley DL, Hart MK, Bavari S.

J Immunol. 2005 Jul 15;175(2):1184-91.

3.

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model.

Kalina WV, Warfield KL, Olinger GG, Bavari S.

Virol J. 2009 Aug 27;6:132. doi: 10.1186/1743-422X-6-132.

5.

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.

Warfield KL, Swenson DL, Negley DL, Schmaljohn AL, Aman MJ, Bavari S.

Vaccine. 2004 Sep 3;22(25-26):3495-502.

PMID:
15308377
6.

Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.

Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY.

J Virol. 2006 Mar;80(6):2738-46.

7.

Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro.

Gupta M, Spiropoulou C, Rollin PE.

Virology. 2007 Jul 20;364(1):45-54. Epub 2007 Mar 27.

9.

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection.

Mahanty S, Gupta M, Paragas J, Bray M, Ahmed R, Rollin PE.

Virology. 2003 Aug 1;312(2):415-24.

10.

Lymphocytic choriomeningitis virus infection is associated with long-standing perturbation of LFA-1 expression on CD8+ T cells.

Andersson EC, Christensen JP, Scheynius A, Marker O, Thomsen AR.

Scand J Immunol. 1995 Jul;42(1):110-8.

PMID:
7543210
11.

Persistent infection with ebola virus under conditions of partial immunity.

Gupta M, Mahanty S, Greer P, Towner JS, Shieh WJ, Zaki SR, Ahmed R, Rollin PE.

J Virol. 2004 Jan;78(2):958-67.

12.

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.

Warfield KL, Posten NA, Swenson DL, Olinger GG, Esposito D, Gillette WK, Hopkins RF, Costantino J, Panchal RG, Hartley JL, Aman MJ, Bavari S.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S421-9.

PMID:
17940979
13.
14.
16.

Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection.

Panchal RG, Bradfute SB, Peyser BD, Warfield KL, Ruthel G, Lane D, Kenny TA, Anderson AO, Raschke WC, Bavari S.

Cell Host Microbe. 2009 Aug 20;6(2):162-73. doi: 10.1016/j.chom.2009.07.003.

17.

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7.

PMID:
17940980

Supplemental Content

Support Center